Upgrade to SI Premium - Free Trial

TG Therapeutics (TGTX) PT Lowered to $19 at H.C. Wainwright

April 18, 2022 6:52 AM
H.C. Wainwright analyst Edward White lowered the price target on TG Therapeutics (NASDAQ: TGTX) to $19.00 (from $68.00) while maintaining ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Categories

Analyst Comments Analyst PT Change

Next Articles